Cargando…

Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments

OBJECTIVE: Cognitive practice effects (PEs) can delay detection of progression from cognitively unimpaired to mild cognitive impairment (MCI). They also reduce diagnostic accuracy as suggested by biomarker positivity data. Even among those who decline, PEs can mask steeper declines by inflating cogn...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanderson-Cimino, Mark, Elman, Jeremy A., Tu, Xin M., Gross, Alden L., Panizzon, Matthew S., Gustavson, Daniel E., Bondi, Mark W., Edmonds, Emily C., Eppig, Joel S., Franz, Carol E., Jak, Amy J., Lyons, Michael J., Thomas, Kelsey R., Williams, McKenna E., Kremen, William S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083463/
https://www.ncbi.nlm.nih.gov/pubmed/35547623
http://dx.doi.org/10.3389/fnagi.2022.847315
_version_ 1784703426438889472
author Sanderson-Cimino, Mark
Elman, Jeremy A.
Tu, Xin M.
Gross, Alden L.
Panizzon, Matthew S.
Gustavson, Daniel E.
Bondi, Mark W.
Edmonds, Emily C.
Eppig, Joel S.
Franz, Carol E.
Jak, Amy J.
Lyons, Michael J.
Thomas, Kelsey R.
Williams, McKenna E.
Kremen, William S.
author_facet Sanderson-Cimino, Mark
Elman, Jeremy A.
Tu, Xin M.
Gross, Alden L.
Panizzon, Matthew S.
Gustavson, Daniel E.
Bondi, Mark W.
Edmonds, Emily C.
Eppig, Joel S.
Franz, Carol E.
Jak, Amy J.
Lyons, Michael J.
Thomas, Kelsey R.
Williams, McKenna E.
Kremen, William S.
author_sort Sanderson-Cimino, Mark
collection PubMed
description OBJECTIVE: Cognitive practice effects (PEs) can delay detection of progression from cognitively unimpaired to mild cognitive impairment (MCI). They also reduce diagnostic accuracy as suggested by biomarker positivity data. Even among those who decline, PEs can mask steeper declines by inflating cognitive scores. Within MCI samples, PEs may increase reversion rates and thus impede detection of further impairment. Within an MCI sample at baseline, we evaluated how PEs impact prevalence, reversion rates, and dementia progression after 1 year. METHODS: We examined 329 baseline Alzheimer’s Disease Neuroimaging Initiative MCI participants (mean age = 73.1; SD = 7.4). We identified test-naïve participants who were demographically matched to returnees at their 1-year follow-up. Since the only major difference between groups was that one completed testing once and the other twice, comparison of scores in each group yielded PEs. PEs were subtracted from each test to yield PE-adjusted scores. Biomarkers included cerebrospinal fluid phosphorylated tau and amyloid beta. Cox proportional models predicted time until first dementia diagnosis using PE-unadjusted and PE-adjusted diagnoses. RESULTS: Accounting for PEs increased MCI prevalence at follow-up by 9.2% (272 vs. 249 MCI), and reduced reversion to normal by 28.8% (57 vs. 80 reverters). PEs also increased stability of single-domain MCI by 12.0% (164 vs. 147). Compared to PE-unadjusted diagnoses, use of PE-adjusted follow-up diagnoses led to a twofold increase in hazard ratios for incident dementia. We classified individuals as false reverters if they reverted to cognitively unimpaired status based on PE-unadjusted scores, but remained classified as MCI cases after accounting for PEs. When amyloid and tau positivity were examined together, 72.2% of these false reverters were positive for at least one biomarker. INTERPRETATION: Even when PEs are small, they can meaningfully change whether some individuals with MCI retain the diagnosis at a 1-year follow-up. Accounting for PEs resulted in increased MCI prevalence and altered stability/reversion rates. This improved diagnostic accuracy also increased the dementia-predicting ability of MCI diagnoses.
format Online
Article
Text
id pubmed-9083463
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90834632022-05-10 Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments Sanderson-Cimino, Mark Elman, Jeremy A. Tu, Xin M. Gross, Alden L. Panizzon, Matthew S. Gustavson, Daniel E. Bondi, Mark W. Edmonds, Emily C. Eppig, Joel S. Franz, Carol E. Jak, Amy J. Lyons, Michael J. Thomas, Kelsey R. Williams, McKenna E. Kremen, William S. Front Aging Neurosci Neuroscience OBJECTIVE: Cognitive practice effects (PEs) can delay detection of progression from cognitively unimpaired to mild cognitive impairment (MCI). They also reduce diagnostic accuracy as suggested by biomarker positivity data. Even among those who decline, PEs can mask steeper declines by inflating cognitive scores. Within MCI samples, PEs may increase reversion rates and thus impede detection of further impairment. Within an MCI sample at baseline, we evaluated how PEs impact prevalence, reversion rates, and dementia progression after 1 year. METHODS: We examined 329 baseline Alzheimer’s Disease Neuroimaging Initiative MCI participants (mean age = 73.1; SD = 7.4). We identified test-naïve participants who were demographically matched to returnees at their 1-year follow-up. Since the only major difference between groups was that one completed testing once and the other twice, comparison of scores in each group yielded PEs. PEs were subtracted from each test to yield PE-adjusted scores. Biomarkers included cerebrospinal fluid phosphorylated tau and amyloid beta. Cox proportional models predicted time until first dementia diagnosis using PE-unadjusted and PE-adjusted diagnoses. RESULTS: Accounting for PEs increased MCI prevalence at follow-up by 9.2% (272 vs. 249 MCI), and reduced reversion to normal by 28.8% (57 vs. 80 reverters). PEs also increased stability of single-domain MCI by 12.0% (164 vs. 147). Compared to PE-unadjusted diagnoses, use of PE-adjusted follow-up diagnoses led to a twofold increase in hazard ratios for incident dementia. We classified individuals as false reverters if they reverted to cognitively unimpaired status based on PE-unadjusted scores, but remained classified as MCI cases after accounting for PEs. When amyloid and tau positivity were examined together, 72.2% of these false reverters were positive for at least one biomarker. INTERPRETATION: Even when PEs are small, they can meaningfully change whether some individuals with MCI retain the diagnosis at a 1-year follow-up. Accounting for PEs resulted in increased MCI prevalence and altered stability/reversion rates. This improved diagnostic accuracy also increased the dementia-predicting ability of MCI diagnoses. Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9083463/ /pubmed/35547623 http://dx.doi.org/10.3389/fnagi.2022.847315 Text en Copyright © 2022 Sanderson-Cimino, Elman, Tu, Gross, Panizzon, Gustavson, Bondi, Edmonds, Eppig, Franz, Jak, Lyons, Thomas, Williams and Kremen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Sanderson-Cimino, Mark
Elman, Jeremy A.
Tu, Xin M.
Gross, Alden L.
Panizzon, Matthew S.
Gustavson, Daniel E.
Bondi, Mark W.
Edmonds, Emily C.
Eppig, Joel S.
Franz, Carol E.
Jak, Amy J.
Lyons, Michael J.
Thomas, Kelsey R.
Williams, McKenna E.
Kremen, William S.
Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
title Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
title_full Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
title_fullStr Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
title_full_unstemmed Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
title_short Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
title_sort practice effects in mild cognitive impairment increase reversion rates and delay detection of new impairments
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083463/
https://www.ncbi.nlm.nih.gov/pubmed/35547623
http://dx.doi.org/10.3389/fnagi.2022.847315
work_keys_str_mv AT sandersonciminomark practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT elmanjeremya practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT tuxinm practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT grossaldenl practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT panizzonmatthews practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT gustavsondaniele practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT bondimarkw practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT edmondsemilyc practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT eppigjoels practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT franzcarole practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT jakamyj practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT lyonsmichaelj practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT thomaskelseyr practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT williamsmckennae practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments
AT kremenwilliams practiceeffectsinmildcognitiveimpairmentincreasereversionratesanddelaydetectionofnewimpairments